Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience

Transplant Proc. 1998 Jun;30(4):1107-9. doi: 10.1016/s0041-1345(98)00171-7.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Graft Rejection / epidemiology*
  • Graft Rejection / pathology
  • Graft Rejection / therapy
  • Heart Transplantation / immunology*
  • Heart Transplantation / mortality
  • Heart Transplantation / pathology
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use*
  • Neoplasms / epidemiology
  • Postoperative Complications / epidemiology
  • Retrospective Studies
  • Steroids / therapeutic use
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3
  • Steroids
  • Cyclosporine
  • Azathioprine